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ABSTRACT
Introduction Early infant diagnosis (EID) of HIV and 
timely initiation of antiretroviral therapy can significantly 
reduce morbidity and mortality among HIV- positive 
infants. Access to EID is limited in many low- income 
and middle- income settings, particularly those in which 
standard care involves dried blood spots (DBS) sent to 
centralised laboratories, such as in Papua New Guinea 
(PNG). We conducted a qualitative exploration of the 
feasibility and acceptability of implementing a point- of- 
care (POC) EID test (Xpert HIV-1 Qualitative assay) among 
health workers and key stakeholders working within the 
prevention of mother- to- child transmission of HIV (PMTCT) 
programme in PNG.
Methods This qualitative substudy was conducted as part 
of a pragmatic trial to investigate the effectiveness of the 
Xpert HIV-1 Qualitative test for EID in PNG and Myanmar. 
Semistructured interviews were undertaken with 5 health 
workers and 13 key informants to explore current services, 
experiences of EID testing, perspectives on the Xpert 
test and the feasibility of integrating and scaling up POC 
EID in PNG. Coding was undertaken using inductive and 
deductive approaches, drawing on existing acceptability 
and feasibility frameworks.
Results Health workers and key informants (N=18) felt 
EID at POC was feasible to implement and beneficial 
to HIV- exposed infants and their families, staff and the 
PMTCT programme more broadly. All study participants 
highlighted starting HIV- positive infants on treatment 
immediately as the main advantage of POC EID compared 
with standard care DBS testing. Health workers identified 
insufficient resources to follow up infants and caregivers 
and space constraints in hospitals as barriers to 
implementation. Participants emphasised the importance 
of adequate human resources, ongoing training and 
support, appropriate coordination and a sustainable supply 
of consumables to ensure effective scale- up of the test 
throughout PNG.
Conclusions Implementation of POC EID in a low HIV 
prevalence setting such as PNG is likely to be both 
feasible and beneficial with careful planning and adequate 
resources.
Trial registration number 12616000734460.
INTRODUCTION
Over 180 000 children aged less than 15 
years are newly infected with HIV world-
wide every year; the vast majority through 
perinatal transmission.1 HIV in children 
progresses more rapidly than in adults, with 
up to 50% mortality in the first 2 years of 
life in the absence of antiretroviral therapy 
(ART).2 3 Early infant diagnosis of HIV (EID) 
and timely ART initiation can significantly 
reduce morbidity and mortality among HIV- 
positive newborns and infants.3 In most 
resource- constrained settings, EID testing is 
based on heel prick dried blood spot (DBS) 
Strengths and limitations of this study
 ► Qualitative explorations of the feasibility and accept-
ability of new healthcare interventions can provide 
valuable information on barriers and enablers to 
implementation.
 ► This is the first study to explore the feasibility and 
acceptability of implementing a point- of- care early 
infant diagnostic test in a low HIV prevalence coun-
try in the Asia- Pacific region.We interviewed health 
workers and key staff within Papua New Guinea’s 
HIV programme to explore their perspectives on the 
factors associated with successful implementation 
of the test within the context of a research project.
 ► The study was implemented in two clinics in the 
Highlands of Papua New Guinea and may, therefore, 
not be generalisable to other provinces or other 
countries in the region.
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samples being sent to central laboratories for virolog-
ical testing using specialised laboratory equipment and 
highly trained personnel.4 This necessitates caregivers 
making a return visit to the clinics to receive test results, 
and may require multiple visits when results are not yet 
available. A review of EID in resource- constrained settings 
found significant disparities in the proportion of DBS test 
results returned to caregivers, with a range of 37%–90%, 
and with the time to results communication ranging from 
9 days to 21 weeks.5 It is estimated that only half of all HIV- 
exposed infants in low- income and middle- income coun-
tries receive an HIV test result within 2 months of birth 
as recommended by WHO guidelines.6 Improvements 
in testing rates and reductions in turnaround times are 
crucial for reducing adverse outcomes for HIV- exposed 
infants.
With an estimated HIV prevalence of 0.8% in the adult 
population (15–49 years), Papua New Guinea (PNG) 
has the highest HIV prevalence in the Pacific region.7–9 
The PNG national HIV policy recommends HIV- exposed 
infants be tested at 6 weeks of age using DBS that are sent 
to the centralised laboratory in the capital, Port Moresby, 
for analysis.10 According to UNAIDS data, 79% of preg-
nant women living with HIV receive antiretroviral medi-
cation for the prevention of mother- to- child transmission 
(PMTCT), and three- quarters of infants (75%) are tested 
for HIV within 2 months of birth.9 PNG has limited trans-
port and telecommunications infrastructure, very diverse 
geography and a predominantly rural population.11–13 
These factors contribute to logistical challenges with 
the transportation of DBS samples and communication 
of results leading to significant delays in the return of 
results to the clinic, to families and, where indicated, ART 
initiation.
According to WHO, a point- of- care (POC) test should be 
easy to use, accurate, affordable, equipment- free, robust, 
deliverable to end users and provide rapid results—ideally 
within 30 min.14 One of the main benefits of POC testing 
is the availability of results and treatment during the same 
visit to a healthcare facility.15 Despite taking 90 min to 
run, the Xpert HIV-1 Qualitative assay (Cepheid, Sunny-
vale, California, USA) is widely considered to be a POC 
test given its ability to provide results on the same day as 
testing.16 The molecular Xpert HIV-1 Qualitative test has 
proven to perform well both in the laboratory and in- field 
evaluations in high prevalence settings.17–19 A recent 
observational study in eight African countries found that 
POC EID testing, including the Xpert HIV-1 Qualitative 
assay, significantly reduced the time to HIV test results 
communication and enabled earlier initiation of ART.20 
However, the availability of a POC test does not always 
translate to its widespread uptake. A number of factors 
can hinder the effective implementation of these tech-
nologies such as policies, user perspectives and health 
system constraints, including cost.21 Examining the feasi-
bility and acceptability of implementing a new healthcare 
intervention is one way to identify these barriers early and 
put strategies in place to address them.22 While numerous 
studies have investigated the acceptability and feasibility 
of various POC tests including CD4 T cell tests and HIV 
rapid tests,23–25 qualitative evidence on the feasibility and 
acceptability of implementing POC EID testing is lacking 
in both low prevalence settings and the Asia- Pacific 
region.
This paper evaluates the feasibility and acceptability of 
implementing the Xpert HIV-1 Qualitative test for EID in 
PNG, and explores the potential for scale- up throughout 
the country.
METHODS
This feasibility and acceptability assessment is one compo-
nent of a cluster- randomised controlled stepped wedge 
trial of the effectiveness of the Xpert HIV-1 Qualitative 
test for EID on HIV- exposed infants in PNG and Myanmar. 
The overall study was undertaken in two hospitals in PNG, 
using both quantitative and qualitative methods.
Patient and public involvement statement
Patients and the public were not directly involved in 
the design, conduct, reporting or dissemination of the 
research. The results of the cluster- randomised trial and 
the qualitative substudies will be disseminated to local 
communities through workshops and written summaries 
of findings.
Study setting
PNG is the largest and most populated of the Pacific 
Island countries.13 The health system faces a number 
of challenges including funding constraints, significant 
shortages of health workers, inconsistent availability of 
basic medication and supplies, and inadequately main-
tained health facilities.12 26 27 It is within this context that 
PNG’s PMTCT programme operates and in which this 
field trial was undertaken in two provincial hospitals: 
Mount Hagen Hospital (Western Highlands Province) 
and Goroka Base Hospital (Eastern Highlands Province). 
These public hospitals were chosen due to the relatively 
high number of pregnant women with HIV undergoing 
care and treatment at respective PMTCT clinics.
Overview of field trial
The field trial was implemented over 14 months with 
6 months of follow- up of enrolled participants. Both study 
sites started in the control phase and moved into the inter-
vention phase at different (randomly assigned) time points, 
following a transition month. During transition prior to 
the intervention phase, the GeneXpert platform was intro-
duced into the facility and research nurses and other health-
care staff were trained on the technology. The machines 
were kept in the same room where patient consultations 
occurred and were primarily run by the research nurses. 
Standard care DBS testing was still undertaken during 
the intervention phase, and caregivers of enrolled infants 
were provided with both Xpert test and DBS results as they 
became available. The result of the Xpert test was used for 
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clinical decision making. Due to the stepped- wedge design 
of the study, Mt. Hagen implemented the intervention for 9 
months and Goroka for 4 months. As part of the trial, qual-
itative data were collected from both caregivers with infants 
enrolled in the study (results presented elsewhere) as well 
as from health workers and key informants.
Qualitative data collection
Towards the end of field implementation, participants for 
this qualitative component were recruited from the two 
study sites in Goroka and Mt. Hagen as well as from the 
national capital Port Mores by, where the National Depart-
ment of Health, Central Public Health Laboratory (CPHL) 
and other key non- government organisations (NGOs) are 
located. Interviews with health workers were undertaken 
either in the hospitals themselves or in a private office in the 
PNG Institute of Medical Research, adjacent to the clinic. 
With consent, key informant interviews took place in the 
offices of interviewees or appropriate rooms within their 
respective organisations in Port Moresby, Mt. Hagen or 
Goroka. The locations of all interviews ensured privacy and 
confidentiality were maintained. Qualitative data collection 
took place from January to April 2018, when both study 
sites were in their last months of field implementation.
Study participants
Five nurses across both sites were purposively recruited 
for in- depth interviews. This included one research nurse 
from each of the two sites who were responsible for study 
implementation, and three nurses working within PMTCT 
services at participating hospitals. Research nurses were 
hired specifically for this field trial and were employed at 
the PNG Institute of Medical Research and seconded to the 
respective clinics prior to implementation. Both research 
nurses had previously worked at their respective hospital, 
were familiar with the setting and the staff and were well 
trained in clinical care. In addition, 13 key informants 
were recruited: senior staff within the PMTCT programme 
in Goroka (n=1), Mt. Hagen (n=2) and Port Moresby 
(n=2); staff from CPHL where standard care EID testing 
is performed (n=2); national government representatives 
(n=3) and staff from international and local NGOs (n=3). 
The international NGO is involved in providing technical 
support and policy advice regarding health in PNG and 
globally; whereas the local NGO provides community- led 
support and advocacy for people living with HIV in PNG. 
Local study investigators purposively identified key infor-
mants to maximise representation across the PMTCT 
programme within PNG. An additional two key informants 
from Port Moresby were contacted and asked to take part in 
the study, however responses were not received.
Research team
The first author (YM) drafted the semistructured inter-
view guides with comprehensive revision and modification 
by the senior author (AK- H) prior to finalisation. Inter-
views were undertaken by an experienced postgraduate 
female social scientist from the PNG Institute of Medical 
Research (MK), and who had no previous involvement in 
the implementation of the main study.
Design
Semistructured interviews with health workers explored 
current PMTCT services, experiences of standard care 
EID based on centralised DBS testing, involvement in 
study implementation including experiences with and 
perspectives on the Xpert HIV-1 Qualitative test for EID, 
acceptability of same- day HIV results, and the feasibility of 
integrating the test into routine clinical care. Interviews 
with key informants focused on their experiences with 
study implementation where applicable, the scope and 
quality of the current PMTCT programme, the perceived 
impact of POC EID on health services, and the feasibility 
of test scale- up throughout PNG.
A total of 18 interviews were conducted with the 
majority lasting between 30 and 90 min. Interviews were 
conducted either in English or Tok Pisin (both national 
languages in PNG), depending on the preference of the 
interviewee, and were digitally recorded with partici-
pants’ consent.
Data analysis
All interviews were transcribed verbatim and, where neces-
sary, translated into English. Each transcript was care-
fully reviewed by the interviewer to ensure the accuracy 
and consistency of transcription and translation. Tran-
scripts were coded using both an inductive and deductive 
approach with NVivo V.11 qualitative data analysis Soft-
ware (QSR International). The first author developed a 
coding framework following an initial reading of the data 
and using existing acceptability and feasibility frameworks 
from the published literature.22 28 29 Following verification 
of the coding framework by the qualitative researcher who 
collected the data and the senior author, the first author 
systematically coded each transcript and analysed the data 
according to the frequency and content of codes and 
themes.
Ethical considerations
Written informed consent was obtained from each 
participant, and all interviews were digitally recorded 
with written consent from interviewees. All identifiable 
information was removed, and no names used to iden-
tify study participants. Electronic transcripts were stored 
on password- protected computers accessible only to 
members of the research team involved in the analysis.
RESULTS
Participant characteristics
A total of 18 participants were included in this qualita-
tive inquiry—5 health workers and 13 key informants. 
An overview of study participants is presented in table 1. 
Both research nurses and most of the clinical staff were 
based at the study sites in Mt. Hagen and Goroka, while 
the majority of key informants involved in HIV policy and 
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programming were based in Port Moresby. All five health-
care workers interviewed were female, and 7 of 13 key 
informants were male.
The main themes identified included challenges with 
current EID services and the consequent need for POC 
EID testing; the perceived impact of POC EID on quality 
of care for infants and caregivers, and the potential bene-
fits for the PMTCT programme more broadly; barriers 
and facilitators to integration of the Xpert test into 
routine clinical care, including factors to be considered 
prior to scale- up of POC EID throughout the country.
Acceptability of POC EID testing
Perceived need for POC EID
POC EID testing was seen by both health workers and key 
informants as a potential way to overcome the existing 
challenges within the current EID programme. Health 
workers, laboratory staff and policy- makers in all sites 
noted the long turnaround time between DBS collec-
tion from HIV- exposed infants and the communication 
of results to facilities and families. Reasons for this delay 
included the absence of a current National Department 
of Health PMTCT programme coordinator since the 
previous year; the availability of only one Roche Amplicor 
HIV-1 Qualitative DNA assay for virological testing (V.1.5; 
Roche Molecular Systems, Branchburg, New Jersey, 
USA) in Port Moresby for testing samples for the entire 
country; the limited number of laboratory staff employed 
to run the machine for EID testing; and the lack of consis-
tently available government funds to maintain testing. 
Inadequate communication channels between hospital 
and laboratory services also contributed to the delay in 
the return of results, with health workers describing tele-
phoning and emailing CPHL but being unable to get 
through to the appropriate department, sometimes due 
to network failures. The lack of clear, consistent guide-
lines for results communication between the hospitals 
and CPHL further exacerbated delays and increased the 
perceived need for a POC EID.
Health workers and key informants described how, in 
some cases turnaround times of several months for EID 
results prevented HIV- infected infants from commencing 
ART in a timely manner. This was acknowledged as having 
profound implications for the health of HIV- exposed 
infants as well as the emotional well- being of caregivers.
We lose a lot of cases (…) where we are sending sam-
ples to CPHL, and they wait for 6 months and some-
times they (infants) die. (Key informant, laboratory, 
Mt. Hagen)
…they (HIV- infected women) don’t want their chil-
dren to become infected. So having to wait for that 
period, finding out whether (their baby is) positive or 
negative is very traumatizing. (Key informant, com-
munity, Port Moresby)
The delay in receiving infants’ HIV results from the 
central laboratory was particularly challenging for health 
workers. Clinical staff described feeling ‘frustrated’, 
Table 1 Overview of study participants by organisation, position type, location and sex
Organisation Position type
No of participants by location (sex)
Mt. Hagen Goroka Port Moresby Total
Healthcare workers   
  PNG Institute of Medical Research Research nurse 1 (F) 1 (F)
  Provincial Hospitals Clinical nurse 1 (F) 2 (F)
  Subtotal 2 3 5
Key informants   
  Provincial Hospitals Clinical 1 (F)
Laboratory 1 (M)
Programmatic 1 (M)
  Port Moresby General Hospital Clinical 1 (F)
Programmatic and clinical 1 (F)
  Central Public Health Laboratory Laboratory 2 (M)
  National Department of Health Programmatic and clinical 1 (F) 1 (M)
  National AIDS Council Secretariat Programmatic and policy 1 (M)
  WHO Programmatic and policy 1 (M)
  Local NGO Community representative 2 (F, M)
Subtotal 3 1 9 13
Total 5 4 9 18
F, female; M, male; NGO, non- government organisation; PNG, Papua New Guinea.
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‘guilty’ and ‘ashamed’ at not being able to provide results 
to caregivers returning to the hospitals.
…when the same mother comes back I usually feel 
ashamed to talk (…). It is my job too so I would give 
excuses that the machine in Moresby is probably dam-
aged or we didn’t receive the email and they didn’t 
send back (the results), and man, I would get cross 
for no good reason on here in front of the mothers. 
(Clinical nurse, Mt. Hagen)
These feelings negatively impacted on job satisfaction 
and reduced the perceived quality of care that could 
be provided. Some caregivers, they shared, would stop 
returning altogether if results were extensively delayed.
Perceived impact of POC EID on quality of care
Being able to commence HIV- infected infants on ART 
‘straight away’ was identified by all study participants as 
the main advantage of POC EID testing, reducing the 
likelihood of child morbidity and mortality.
…we saved four babies with the result of the 
(GeneXpert) machine. They are tolerating (ART) re-
ally well. (Research nurse, Mt. Hagen)
Another benefit of POC EID testing was a sense of job 
satisfaction at providing good quality care to caregivers 
and babies.
For the mothers, they need to hear the results soon-
er, and we also want to hear the results sooner also 
for our jobs, we will feel motivated to work. (Clinical 
nurse, Mt. Hagen)
Research nurses reported a reduction in lost to 
follow- up of HIV- exposed infants and their caregivers due 
to the provision of same- day results. Hospital staff in the 
study sites stated that more caregivers were coming to 
the clinics for EID testing as a result of the availability of 
same- day results than would normally be expected with 
standard EID testing. Health workers felt that caregivers 
were more motivated to return to the clinic for appoint-
ments in order to find out if their child or children had 
HIV, and that the majority were willing to wait for 90 min 
to receive HIV test results.
She (mother) doesn’t want the baby to be infected 
like herself, so she made her time available, and she 
came on time. (Research nurse, Goroka)
Health workers acknowledged that not all caregivers 
were able to wait for 90 min, in addition to the time for 
sample collection and preparation. POC testing was not 
able to address competing priorities that made it diffi-
cult for caregivers to stay at the clinic. For example, the 
research nurse in Mt. Hagen reported that one mother 
of twins was unable to wait for the test results because her 
husband ‘chased her away’ from the clinic. Both twins 
were found to be HIV- positive, and while staff made every 
effort to contact the family, it was not until after one twin 
had died that the family returned to the health facility.
The research nurse in Mt. Hagen highlighted poten-
tial risks associated with same- day results for HIV- exposed 
infants. Having received an HIV- negative test result for 
their child, some mothers may want to stop any ongoing 
HIV exposure for the infant by discontinuing breast 
feeding, despite breast feeding being recommended in 
national and international guidelines.10 30 This risk was 
heightened in infants receiving same- day results who are 
likely to be much younger than those using the standard 
care DBS test.
…sometimes when they hear this result, when the 
baby is negative, they quickly want to put the baby 
on Lactogen (formula) because they know that, their 
baby is negative so they don’t want to breast feed any-
more. (Research nurse, Mt Hagen)
Another perceived risk was that mothers presenting 
for their infant’s first EID test might not understand that 
further testing would still be required after cessation of 
breast feeding to definitively confirm the HIV status of 
the child, and may therefore not return to the clinic for 
further HIV testing. This was less of an issue with standard 
care testing as caregivers often brought their children 
back to the clinic multiple times to see if standard care 
results were available, whereas same- day testing reduced 
the need for multiple visits. Health workers felt that good 
quality counselling and provision of accurate information 
to caregivers immediately after provision of POC results 
could mitigate these risks.
Potential benefits for PMTCT programme
All interviewees believed the Xpert HIV-1 Qualita-
tive test for EID would be beneficial for the PMTCT 
programme and the country overall. As one key infor-
mant described it, POC EID testing would bring the 
PMTCT programme to the ‘next level’. Same- day EID 
results were seen as essential for improving maternal and 
child health services, and substantially impacting on the 
HIV epidemic in PNG.
I think we’re making progress against targets that we 
are setting, the 2030 targets of, zero new infection by 
2030. So, if we’re able to strengthen the PPTCT pro-
gram, …the program will be matured, so that’s a suc-
cess. (Key informant, programmatic, Port Moresby)
By providing same- day results and reducing lost to 
follow- up, POC EID was seen as a way to improve reporting 
of paediatric HIV and enable better monitoring and eval-
uation of the effectiveness of the PMTCT programme in 
PNG. Laboratory staff from CPHL also appreciated the 
benefits of POC EID testing in health facilities, particu-
larly in terms of reducing the strain on overburdened 
central laboratory services responsible for EID testing 
throughout the entire country.
Study participants highlighted the likely impact of POC 
testing on the efficiency of EID services, with benefits for 
patients, staff and the health system more broadly.
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I think it’s going to have a great impact in terms of 
getting results within few hours and get them treat-
ed. So actually, we are saving lives. We identify in get-
ting patients on treatment, and we are actually saving 
lives; that’s impact. And I think this is a great benefit 
for the patients and it’s for the country as well.
(Key informant, laboratory, Mt. Hagen)
Key informants at the community, programmatic and 
policy levels identified the additional testing available 
through the GeneXpert platform, including tuberculosis 
and HIV viral load monitoring, as added benefits of the 
technology. This was perceived as an important facilitator 
for scale up and sustainability.
Feasibility of implementing POC EID
Human resources
Research nurses were recruited by the PNG Institute of 
Medical Research and colocated at both study sites to 
undertake study procedures and conduct POC EID testing 
during the intervention phase of the study. In some cases, 
they also relayed test results to caregivers. According to 
the health workers interviewed, the presence of these 
additional staff made implementation feasible at the 
study sites. Health workers acknowledged that without 
these research nurses, it would have been challenging 
to integrate POC EID into their existing workloads. This 
was especially true in Mt. Hagen, where the number of 
patients presenting for EID increased substantially during 
the study period, with participants hypothesising that 
this was due to the presence of the GeneXpert machine. 
Despite acknowledging the potential for an increased 
workload, the majority of health workers were willing to 
spend the time conducting POC EID due to its perceived 
importance for the quality of care provided.
In contrast, some health workers suggested that access 
to POC EID would reduce clinic staff workload by 
decreasing the amount of time spent transporting and 
following up on DBS samples sent for centralised labora-
tory testing in Port Moresby.
This (Xpert HIV-1 Qualitative test) is making my job 
much easier (…). It’s not like before where I used to 
go and send the samples to CPHL. If this study goes 
well, the thing (GeneXpert® machine) is already in-
stalled. I will not move around and waste my time out 
at the post office or wait for the result to come back. 
(Clinical nurse, Goroka)
Participants emphasised the importance of training and 
hiring an appropriate number of staff in facilities where 
POC EID services would be implemented. According to 
health workers, training on the GeneXpert machine and 
Xpert HIV-1 Qualitative test should be similar to that 
provided in this study with both theoretical and practical 
components, a focus on preparing the cartridges and 
running the test, the availability of written guidelines 
on testing procedures, and adequate supervision and 
support.
Key informants identified the importance of consistent 
implementation of standard operating procedures on 
all aspects of running the test as well as mechanisms for 
quality control and external quality assurance. Labora-
tory staff in particular described the need for adequate 
support, supervision and mentoring of clinical staff not 
familiar with laboratory testing procedures.
We need to train nurses (…). They need to work very 
very closely with the lab persons or the experts in 
there. And the other challenge is that, because it’s a 
machine that is being used in the lab, we try to take it 
out from the lab, put it in the clinic and my challenge 
is that the quality and the results being produced be-
cause there are likely to be mistakes being added. So 
there needs to be some sort of quality check on the 
reports that we produce. (Key informant, laboratory, 
Mt. Hagen)
Coordination
Key informants highlighted the need for appropriate 
coordination of the scale- up of any new technology 
throughout the country. Multiple participants mentioned 
the importance of the National Department of Health 
taking ownership of a national programme, especially 
with regard to sustainable funding and essential coordi-
nation for driving the scale- up as well as maintaining the 
quality of services.
Other key informants felt that decentralising the EID 
services would be more beneficial to the effectiveness of 
the programme, ensuring that someone was available at 
each hospital to address any unforeseen challenges.
Integration of POC EID into health services
While the majority of Xpert HIV-1 Qualitative test results 
were provided on the same day, health workers described 
instances of patients arriving late in the day and conse-
quently having to return the next day for their results. 
Although no longer POC testing by definition, health 
workers agreed that next day results were still faster 
than standard care. The clinics attempted to maximise 
same- day results by prioritising caregivers bringing their 
children in for EID testing and commencing these tests 
immediately wherever feasible. The research nurses also 
identified the ability to store infant blood samples for up 
to 72 hours as an advantage of the test, making testing 
easier to integrate into routine clinical care. Some health 
workers also appreciated that the 90 min during which the 
Xpert HIV-1 Qualitative test was running could be used to 
undertake other clinical duties such as health education.
One particular challenge that the research team 
faced in implementing POC EID in the two study sites 
was following up caregivers who were unable to wait 
for same- day results and did not return to the clinic the 
following day. Caregivers were difficult to trace because 
no systems were in place at either study site for follow- up, 
research nurses did not have consistent access to a vehicle 
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for home visits, and many caregivers were not contactable 
by mobile phone.
The communication system that was another chal-
lenge that I had…Sometimes when (caregivers) give 
their numbers to us, someone else is answering the 
phone and not this client. They lose their phones 
sometimes, and that’s another challenge about 
follow- ups. (Research nurse, Mt. Hagen)
Infrastructure
Identifying an appropriate location for the GeneXpert 
machine within the clinics was important for imple-
menting POC EID testing. Both study sites have a high 
patient load and limited space, and health workers high-
lighted the challenges of trying to fit the new technology 
into the clinic.
Ensuring a sustainable and consistent supply of test 
cartridges was also identified as an important aspect of 
integrating POC EID testing into routine clinical care. 
While both sites had sufficient numbers of cartridges 
throughout the study, maintaining the supply proved 
challenging at times as enrolment numbers increased 
unexpectedly in Mt. Hagen. The Alere PIMA machine 
was cited as an example of a technology that has not been 
sustainably scaled up in PNG, with sites currently lacking 
access to cartridges and therefore being unable to run 
POC CD4 tests. Ensuring the sustainability of POC EID 
testing was believed to require clear delegation of respon-
sibilities for ordering cartridges and necessary supplies. 
Multiple key informants identified the cost of cartridges 
as a potential challenge to sustainability.
We are happy for the scaling up to go rural, especially 
at the district level but the funding is a big problem 
for us. Who will now buy the GeneXpert Machine? 
Who will pay for the cartridges? (Key informant, pro-
grammatic, Goroka)
Maintenance of the GeneXpert machine was also iden-
tified as a potential challenge to scale- up, with key inform-
ants raising concerns about machines not being used if 
they broke down due to inadequate maintenance plans.
DISCUSSION
This is the first study to explore the feasibility and accept-
ability of implementing a POC EID test in a low HIV prev-
alence, lower- middle- income Asia- Pacific country. Health 
workers and key staff within the PMTCT programme 
found the Xpert HIV-1 Qualitative test for EID accept-
able and feasible to implement within the context of a 
research project and potentially more broadly, and all 
participants believed that the test would reduce time 
to treatment initiation and improve the quality of care 
provided to HIV- exposed infants and their families. A 
nurse- led model of care combined with the presence of 
research nurses at the two study sites enabled immediate 
initiation of ART for infants found to be HIV- infected 
on the same day as testing. POC EID has been demon-
strated to significantly reduce the time to provision of 
HIV test results and enable earlier ART initiation.20 The 
potential benefits of scaling up POC EID are particularly 
important in a context like PNG where PMTCT services 
are constrained, and preventable transmission of HIV 
from mothers to their children occurs, although the cost- 
effectiveness in a low prevalence setting warrants further 
investigation.
According to study participants, the primary benefit 
of POC EID testing is the provision of same- day results 
and immediate initiation of treatment for HIV- positive 
infants. Research has clearly shown the importance of 
early treatment initiation for the health of HIV- exposed 
infants, with an up to 76% reduction in infant mortality.2 
POC EID has recently been shown to be effective in 
improving the turnaround time of results and enabling 
earlier ART initiation in high HIV prevalence settings.20 
While our study highlights the considerable potential 
of the Xpert HIV-1 Qualitative test to improve quality 
of care within the EID programme in PNG, a number 
of key strategies need to be in place within the PMTCT 
cascade to maximise impact.5 For example, all pregnant 
women must have access to HIV testing and treatment, 
and mechanisms for efficient patient follow- up need to 
be established.5
Health workers interviewed in this study highlighted 
two potential challenges with the provision of same- day 
EID results. First, obtaining an HIV result early could 
conceivably impact on a caregiver’s motivation to return 
to the clinic for final confirmatory testing after the 
cessation of breastfeeding. It is likely, however, that the 
benefits of finding out an infant’s HIV status on the 
same day as testing outweigh the risks of potential lost 
to follow- up in the future, especially considering that 
caregivers may become lost to follow- up within standard 
EID programmes and consequently never receive a test 
result for their infant. A study looking at barriers to EID 
in Malawi found that one third of women living with HIV 
did not return for their child’s HIV test results, primarily 
due to transportation challenges.31 Promisingly, a recent 
qualitative inquiry in Lesotho looking at very early diag-
nosis of HIV in infants found that mothers and health 
workers did not believe that birth testing would impact on 
the likelihood of returning to health facilities for subse-
quent HIV testing.32
The second identified challenge with same- day testing 
was the potential cessation of breastfeeding by mothers 
whose infants were found to be HIV negative. In the 
context of lifelong ART for all adults living with HIV 
including pregnant women, WHO recommends exclusive 
breastfeeding for the first 6 months of life and continued 
breast feeding up to 2 years and beyond for all infants 
born to women living with HIV.33 Particularly in a setting 
such as PNG with a high burden of childhood illness, early 
cessation of breast feeding could have significant conse-
quences for infant and child morbidity and mortality.34 In 
addition, a qualitative study in PNG found that front- line 
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health workers are not aware of best practice infant 
feeding guidelines within the context of HIV.35 With wider 
scale- up of POC EID in PNG, monitoring the impact of 
same- day results on breastfeeding practices would be 
advisable. Further promotion of exclusive breastfeeding 
through individual and group counselling at antenatal 
and postnatal care by both health workers and peer coun-
sellors would likely mitigate any detrimental impact of 
POC EID testing on breastfeeding rates.36
Within the context of a research project, health 
workers found implementation of POC EID to be 
feasible in the two study sites. The availability of addi-
tional staff members to perform the test was essential 
to ensure integration of the testing procedure into 
routine clinical care. Research nurses were also respon-
sible for study- specific data collection, which would not 
be required once the test was scaled up outside of the 
research context. Performing the Xpert HIV-1 Qualita-
tive test does have an impact on the workload of clinic 
staff, particularly as the test is more complex and takes 
longer to run than the average lateral flow POC device. 
A systematic review of the acceptability and feasibility 
of POC CD4 testing identified increased staff work-
load as an important operational challenge.24 However, 
health workers involved in our project were very opti-
mistic about the potential for integration of the test 
into routine practice, and many were willing to increase 
their own workload for the benefit of their patients. A 
recent study in South Africa found that health workers 
were willing and able to manage the additional workload 
associated with POC EID testing using the Alere q 1/2 
Detect device, and concluded that POC EID testing was 
highly acceptable in a field setting.37 Ensuring adequate 
staffing in clinics where POC EID is implemented will 
be crucial for sustainability, especially within a health 
system facing a chronic shortage of health workers 
and considerable resource constraints, as is the case in 
PNG.12 27 38
Study participants identified the importance of 
adequate human resources; ongoing training and 
support; a sustainable supply chain; sufficient space for 
the GeneXpert machine; and effective coordination 
and oversight to maximise the sustainability of POC EID 
in PNG. These components are similar to those high-
lighted in other feasibility studies of novel healthcare 
interventions, particularly in low- income and middle- 
income country settings. A lack of coordination of 
maternal and infant HIV services negatively impacted 
on EID outcomes in a study in Malawi39 and a review of 
barriers to scale up of POC technologies also identified 
infrastructure, workflow, training and supply chain as 
important challenges.21 Importantly, these key drivers 
of sustainability have been reported by health workers 
as significant challenges within the current PMTCT 
programme in PNG.38
Ensuring adequate resources to follow- up patients was 
identified in our study as an important component of 
sustainable scale- up of the Xpert HIV-1 Qualitative test. 
Tynan et al38 also describe patient follow- up as a perva-
sive barrier to successful implementation of the PMTCT 
programme in PNG. It is, however, worth noting that 
the availability of POC EID testing is likely to reduce the 
need for active tracing of mother–infant pairs for results 
communication compared with standard care DBS 
testing.
This study has a number of limitations that impact on 
the interpretation of the findings. While the qualitative 
researcher facilitating the semistructured interviews was 
not part of the overall study team, she is a staff member of 
one of the organisations leading the project. Therefore, it 
is possible that social desirability bias could have resulted 
in a tendency towards a focus on the positive aspects of 
POC EID by participants. It is also possible that key infor-
mants who were contacted to take part in this qualita-
tive inquiry but did not respond to these requests had a 
different opinion to those who were interviewed. Finally, 
the overall study was only implemented in two clinics in 
the Highlands of PNG and may therefore not be gener-
alisable to other provinces. Obtaining the perspectives of 
key stakeholders in Port Moresby with considerable expe-
rience of the national EID programme helped to mitigate 
this risk.
CONCLUSIONS
The Xpert HIV-1 Qualitative test is acceptable and 
feasible to implement in a low prevalence, lower- middle- 
income country setting such as PNG within a research 
context and potentially more broadly, and will likely be 
beneficial to the national PMTCT programme. POC 
EID has the potential to reduce the time to initiation 
of life- saving treatment among HIV- infected infants 
in PNG. Ensuring the availability of sufficient human 
resources, sustainable funding and effective coordina-
tion are critical for successful implementation of POC 
EID in this setting.
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